Biology Reference
In-Depth Information
22. Zhong X, Maxwell EJ, Ratnayake C, Mack S, Chen DDY.
Flow-through microvial facilitating interface of capillary
isoelectric focusing and electrospray ionization mass
spectrometry. Anal Chem 2011;
analysis for biomarker evaluation in chronic kidney
disease. J Proteome Res 2009;
:268
e
81.
34. Kistler AD, Mischak H, Poster D, Dakna M,
Wuthrich RP, Serra AL. Identi
8
:8748
e
55.
23. Busnel J-M, Schoenmaker B, Ramautar R, Carrasco-
Pancorbo A, Ratnayake C, Feitelson JS, et al. High
capacity capillary electrophoresis-electrospray ioniza-
tion mass spectrometry: coupling a porous sheathless
interface with transient-isotachophoresis. Anal Chem
2010;
cation of a unique
83
urinary biomarker pro
le in patients with autosomal
dominant polycystic kidney disease. Kidney Int 2009;
:
76
89
e
96.
35. Good DM, Zurbig P, Argiles A, Bauer HW, Behrens G,
Coon JJ, et al. Naturally occurring human urinary
peptides for use in diagnosis of chronic kidney disease.
Mol Cell Proteomics 2010;
:9476
e
83.
24. Ramautar R, Busnel J-M, Deelder AM, Mayboroda OA.
Enhancing the coverage of the urinary metabolome by
sheathless capillary electrophoresis-mass spectrometry.
Anal Chem 2012;
82
:2424
e
37.
36. Raedler TJ, Wittke S, Jahn H, Koessler A, Mischak H,
Wiedemann K. Capillary electrophoresis mass spec-
trometry as a potential tool to detect lithium-induced
nephropathy: preliminary results. Prog Neuropsycho-
pharmacol Biol Psychiatry 2008;
9
:885
e
92.
25. Drube J, Zurbig P, Schiffer E, Lau E, Ure B, Gluer S,
et al. Urinary proteome analysis identi
84
es infants but
not older children requiring pyeloplasty. Pediatr Nephrol
2010;
:673
e
8.
37. Weissinger EM, Schiffer E, Hertenstein B, Ferrara JL,
Holler E, Stadler M, et al. Proteomic patterns predict
acute graft-versus-host disease after allogeneic hema-
topoietic stem cell
32
:1673
e
8.
26. Theodorescu D, Schiffer E, Bauer HW, Douwes F,
Eichhorn F, Polley R, et al. Discovery and validation of
urinary biomarkers for prostate cancer. Proteomics Clin
Appl 2008;
25
transplantation. Blood 2007;
109
:
5511
e
9.
38. Haselberg R, de Jong GJ, Somsen GW. Capillary
electrophoresis-mass spectrometry for the analysis of
intact proteins 2007-2010. Electrophoresis 2011;
:556
e
70.
27. Schiffer E, Vlahou A, Petrolekas A, Stravodimos K,
Tauber R, Geschwend JE, et al. Prediction of muscle-
invasive bladder cancer using urinary proteomics.
Clin Cancer Res 2009;
2
:66
e
82.
39. Albalat A, Mischak H, Mullen W. Clinical application
of urinary proteomics/peptidomics. Expert Rev Proteo-
mics 2011;
32
:4935
e
43.
28. Schiffer E, Bick C, Grizelj B, Pietzker S, Schofer W.
Urinary proteome analysis for prostate cancer diag-
nosis: cost-effective application in routine clinical
practice in Germany. Int J Urol 2012;
15
:615
e
29.
40. Mischak H, Schanstra JP. CE-MS in biomarker
discovery, validation, and clinical application. Proteo-
mics Clin Appl 2011;
8
:118
e
25.
29. Haubitz M, Good DM, Woywodt A, Haller H,
Rupprecht H, Theodorescu D, et al. Identi
:9
e
23.
41. Metzger J, Chatzikyrkou C, Broecker V, Schiffer E,
Jaensch L, Iphoefer A, et al. Diagnosis of subclinical and
clinical acute T-cell-mediated rejection in renal trans-
plant patients by urinary proteome analysis. Proteomics
Clin Appl 2011;
19
5
cation and
validation of urinary biomarkers for differential diag-
nosis and evaluation of therapeutic intervention in anti-
neutrophil cytoplasmic antibody-associated vasculitis.
Mol Cell Proteomics 2009;
:322
e
33.
42. Zuberovic A, Wetterhall M, Hanrieder J, Bergquist J. CE
MALDI-TOF/TOF MS for multiplexed quanti
5
:2296
e
307.
30. Zimmerli LU, Schiffer E, Zurbig P, Good DM,
Kellmann M, Mouls L, et al. Urinary proteomic
biomarkers in coronary artery disease. Mol Cell Proteomics
2008;
8
cation
of proteins in human ventricular cerebrospinal
fluid.
:1836
e
43.
43. Wiese S, Reidegeld KA, Meyer HE, Warscheid B.
Protein labeling by iTRAQ: a new tool for quantitative
mass spectrometry in proteome research. Proteomics
2007;
Electrophoresis 2009;
30
:290
e
8.
31. von Zur Muhlen C, Schiffer E, Zuerbig P, Kellmann M,
Brasse M, Meert N, et al. Evaluation of urine proteome
pattern analysis
7
ect coro-
nary artery atherosclerosis in symptomatic patients.
J Proteome Res 2009;
for
its potential
to re
:340
e
50.
44. Giddings JC. Two-dimensional separations: concept
and promise. Anal Chem 1984;
7
:335
e
45.
32. Snell-Bergeon JK, Maahs DM, Ogden LG, Kinney GL,
Hokanson JE, Schiffer E, et al. Evaluation of urinary
biomarkers for coronary artery disease, diabetes, and
diabetic kidney disease. Diabetes Technol Ther 2009;
8
:1260.
45. Li Y, Champion MM, Sun L, Champion PAD, Wojcik R,
Dovichi NJ. Capillary zone electrophoresis-electrospray
ionization-tandem mass spectrometry as an alternative
proteomics platform to ultraperformance liquid
chromatography-electrospray ionization-tandem mass
spectrometry for samples of intermediate complexity.
Anal Chem 2012;
56
11
:
1
e
9.
33.
Jantos-Siwy J, Schiffer E, Brand K, Schumann G,
Rossing K, Delles C, et al. Quantitative urinary proteome
:1617
e
22.
84
Search WWH ::
Custom Search